Clinical Trial Update: A RCT of Oral S-1 in Combination With Sequential HAIC of Oxaliplatin After TACE in Patients With Advanced HCC [Phase 4]

View source ↗

Summary

A Phase 4 randomized trial evaluating oral S-1 in combination with sequential hepatic arterial infusion of oxaliplatin after transarterial chemoembolization for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• OXALIPLATIN (Oxaliplatin)
• S-1 (tegafur/gimeracil/oteracil)

Snippet

Sponsor: Zhu Xu | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN